Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Reconstituted membranes of tumour cells (proteoliposomes) induce specific protection to murine lymphoma cells

Summary

Antigens presented on cell membranes or on liposomes are usually more immunogenic than antigens in soluble form, this being one of the reasons for the weak immunogenicity of extracted tumour-associated transplantation antigens (TATA). The main objective of this study is to solubilize TATA from tumour cells and to present them on a membrane-like structure to the immune system. Crude tumour cell membranes of SL2 lymphosarcoma cells (a spontaneously arising, weakly immunogenic tumour) were solubilized with octylglucoside or sodium deoxycholate, and reconstituted membranes (proteoliposomes) were prepared by detergent removal. Mice immunized s.c. with reconstituted membranes were protected against an i. p. challenge with tumour cells. Although octylglucoside solubilized only 41% of the membrane proteins, the reconstituted membranes were as immunoprotective as crude membranes. (Glyco)proteins were probably the major membrane components in the reconstituted membranes that induce immunoprotection, as mice immunized with preparations constituted of (glyco)lipids from SL2 cells could not reject SL2 cells. If Freund's complete adjuvant was used with the first immunization injection, no potentiation of the elicited immune responses was observed. Besides the membrane TATA, SL2 cells contained an apparently non-membrane-bound TATA, which was found in the cytoplasm. It is concluded that detergent solubilization of membranes and subsequent preparation of reconstituted membranes can be used to obtain membrane tumour-associated antigens that retain activity for induction of protective tumour immunity. The major advantage of this method is that membrane proteins are solubilized and are subsequently presented on a membrane-like structure that resembles the tumour cell membrane. On theoretical and practical grounds it provides a promising alternative for whole-cell vaccines.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Ansel S, Blangy D (1984) In vivo induction of tumor-specific immunity by glycolipid extracts of SV40-transformed cells. Int J Cancer 34: 555

  2. 2.

    Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911

  3. 3.

    Burakoff SJ, Mescher MF (1982) Reconstituted membranes and liposomes in the study of lymphocyte interactions. Cell Surface Rev 8: 173

  4. 4.

    Bystryn J-C (1990) Tumor vaccines. Cancer Metastasis Rev 9: 81

  5. 5.

    Bystryn J-C, Oratz R, Harris MN, Roses DF, Golomb FM, Speyer JL (1988) Immunogenicity of a polyvalent melanoma antigen vaccine in humans. Cancer 61: 1065

  6. 6.

    Coggin JH, Gillis LD, Payne WJ (1984) Differential extraction of tumor-specific transplantation antigen and embryonic antigen from simian virus-40 and adenovirus 7-induced sarcoma cells of hamsters with 1-butanol and 3 M potassium chloride. J Natl Cancer Inst 72: 853

  7. 7.

    Dullens HFJ, Hilgers J, Spit BJ, De Heer E, De Weger RA, Van Basten CDH, Den Otter W (1982) Staging, growth properties and metastatic behaviour of a transplantable murine T-cell lymphoma. Int J Tiss React 4: 15

  8. 8.

    Dullens HFJ, Schakenraad S, Oostdijk A, Vuist W, Van Der Maas M, Den Otter W (1986) Specific tumoricidal activity of cytotoxic macrophages and cytotoxic lymphocytes. Cancer Immunol Immunother 22: 100

  9. 9.

    Fast LR, Fan DP (1978) Dissociated and reconstituted subcellular alloantigen capable of stimulating mouse cytotoxic T lymphocytes in vitro. J Immunol 120: 1092

  10. 10.

    Fiske CH, Subbarow Y (1925) The colorimetric determination of phosphorus. J Biol Chem 66: 375

  11. 11.

    Ghosh SK, White LM, Ghosh R, Bankert RB (1990) Vaccination with membrane-associated idiotype provides greater and more prolonged protection of animals from tumor challenge than the soluble form of idiotype. J Immunol 145: 365

  12. 12.

    Gregoriadis G (1990) Immunological adjuvants: a role for liposomes. Immunol Today 11: 89

  13. 13.

    Hakomori S (1984) Tumor-associated carbohydrate antigens. Annu Rev Immunol 2: 103

  14. 14.

    Hakomori S, Kannagi R (1986) Carbohydrate antigens in higher animals. In: Handbook of experimental immunology: vol 1. Immunochemistry. Blackwell, Oxford, p 91

  15. 15.

    Hakomori S, Siddiqui B (1974) Isolation and characterization of glycospingolipid from animal cells and their membranes. Methods Enzymol 32: 345

  16. 16.

    Hellström KE, Hellström I (1989) Oncogene-associated tumor antigens as targets for immunotherapy. FASEB J 3: 1715

  17. 17.

    Hoover HC, Hanna MG (1989) Active immunotherapy in colorectal cancer. Semin Surg Oncol 5: 436

  18. 18.

    Jiskoot W, Teerlink T, Beuvery EC, Crommelin DJA (1986) Preparation of liposomes via detergent removal from mixed micelles by dilution. The effect of bilayer composition and process parameters on liposome characteristics. Pharm Weekbl [Sci] 8: 259

  19. 19.

    LeGrue SJ (1984) Carrier and adjuvant properties of liposome-borne tumor-specific antigens. Cancer Immunol Immunother 17: 135

  20. 20.

    LeGrue SJ (1985) Noncytolytic extraction of cell surface antigens using butanol. Cancer Metastasis Rev 4: 209

  21. 21.

    LeGrue SJ, Kahan BD, Pellis NR (1980) Extraction of a murine tumor-specific transplantation antigen with 1-butanol: I. Partial purification by isoelectric focusing. J Natl Cancer Inst 65: 191

  22. 22.

    LeGrue SJ, Macek CM, Kahan BD (1982) Noncytolytic extraction of murine tumor-specific transplantation antigens with the nonionic detergent octyl-β-d-glucopyranoside. J Natl Cancer Inst 69: 131

  23. 23.

    Livingston PO, Calves MJ, Natoli EJ (1987) Approaches to augmenting the immunogenicity of the ganglioside GM2 in mice: purified GM2 is superior to whole cells. J Immunol 138: 1524

  24. 24.

    Los G, De Weger RA, Moberts RMP, Van Loveren H, Sakkers RJ, Den Otter W (1987) The absence of delayed-type hypersensitivity reactivity in a syngeneic murine tumour system. Immunology 62: 89

  25. 25.

    Maas RA, Dullens HFJ, De Jong WH, Den Otter W (1989) Immunotherapy of mice with a large burden of disseminated lymphoma with low-dose interleukin 2. Cancer Res 49: 7037

  26. 26.

    Marx JL (1989) Cancer vaccines show promise at last. Science 245: 813

  27. 27.

    Minami A, Mizushima Y, Takeichi N, Hosokawa M, Kobayashi H (1979) Dissociation of anti-tumor immune responses in rats immunized with solubilized tumor-associated antigens from a methyl-cholanthrene-induced fibrosarcoma. Int J Cancer 23: 358

  28. 28.

    Mitchell MS, Kan-Mitchell J, Kempf RA, Harel W, Shau H, Lind S (1988) Active specific immunotherapy for melanoma: phase I trial of allogeneic lysates and a novel adjuvant. Cancer Res 48: 5883

  29. 29.

    Natori T, Law LW, Appella E (1977) Biological and biochemical properties of Nonidet P40-solubilized and partially purified tumor-specific antigens of the transplantation type from plasma membranes of a methylcholanthrene-induced sarcoma. Cancer Res 37: 3406

  30. 30.

    Phillips NC, Loutfi A, Kareem M, Shibata H, Baines M (1989) Experimental and clinical evaluation of liposome-tumor antigen immunotherapy: In: Liposomes in the therapy of infectious diseases and cancer. Liss, New York, p 15

  31. 31.

    Ritter G, Boosfeld E, Adluri R, Calves M, Oettgen HF, Old LJ, Livingston P (1991) Antibody response to immunization with ganglioside GD3 and GD3 congeners (lactones, amide and gangliosidol) in patients with malignant melanoma. Int J Cancer 48: 379

  32. 32.

    Schroit AJ, Key ME (1983) Induction of syngeneic tumour-specific immunity by liposomes reconstituted with L2C tumour-cell antigens. Immunology 49: 431

  33. 33.

    Seigler HF, Wallack MK, Vervaert CE, Bash JA, Roberson KM, Stuhlmiller GM (1989) Melanoma patient antibody responses to melanoma tumor-associated antigens defined by murine monoclonal antibodies. J Biol Response Mod 8: 37

  34. 34.

    Shibata R, Noguchi T, Sato T, Akiyoshi K, Sunamoto J, Shiku H, Nakayama E (1991) Induction of in vitro and in vivo anti-tumor responses by sensitization of mice with liposomes containing a crude butanol extract of leukemia cells and transferred intermembranously with cell-surface proteins. Int J Cancer 48: 434

  35. 35.

    Simcik WJ, Kripke ML, Sheu T-L, LeGrue SJ (1988) Differential extraction of tumor-specific antigens from two ultraviolet light-induced murine fibrosarcomas with the use of 1-butanol. Cancer Res 48: 7004

  36. 36.

    Srivastava PK, Old LJ (1988) Individually distinct transplantation antigens of chemically induced mouse tumors. Immunol Today 9: 78

  37. 37.

    Turner MJ, Cresswell P, Parham P, Strominger JL, Mann DL, Sanderson AR (1975) Purification of papain-solubilized histocomptability antigens from a cultured human lymphoblastoid line, RPMI 4265. J Biol Chem 250: 4512

  38. 38.

    Wessel D, Flügge UI (1984) A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal Biochem 138: 141

Download references

Author information

Correspondence to Joep J. Bergers.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Bergers, J.J., Den Otter, W., De Groot, J.W. et al. Reconstituted membranes of tumour cells (proteoliposomes) induce specific protection to murine lymphoma cells. Cancer Immunol Immunother 34, 233–240 (1992). https://doi.org/10.1007/BF01741791

Download citation

Key words

  • Tumour vaccine
  • Liposomes
  • Reconstituted membranes
  • Lymphoma cells